Largest pharmaceutical companies in the United States by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 44 pharmaceutical companies in the United States ranked by earnings, at CHF 22.6B, ahead of Eli Lilly (CHF 17.4B) and Merck & Co (CHF 15.4B). Figures as of 20 Nov 2026, 05:38 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Johnson & JohnsonCHF 22.6B
- Median
- -CHF 40.2M
- Combined market value
- CHF 3.15T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | CHF 22.6B | CHF 541.6B | CHF 224.99 | 2.04% down | 34% up | ||
| 2 | Eli LillyLLY · Health Care | CHF 17.4B | CHF 1.01T | CHF 1,137.93 | 2.29% down | 33% up | ||
| 3 | Merck & CoMRK · Health Care | CHF 15.4B | CHF 275.7B | CHF 111.85 | 3.61% down | 45% up | ||
| 4 | PfizerPFE · Health Care | CHF 6.5B | CHF 132.2B | CHF 23.19 | 1.85% down | 15% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | CHF 5.9B | CHF 100.4B | CHF 49.13 | 2.05% down | 30% up | ||
| 6 | Abbott LaboratoriesABT · Health Care | CHF 5.5B | CHF 151.5B | CHF 87.48 | 0.58% down | 16% down | ||
| 7 | Regeneron PharmaceuticalsREGN · Health Care | CHF 3.8B | CHF 80.4B | CHF 777.65 | 2.35% down | 28% up | ||
| 8 | AbbVieABBV · Health Care | CHF 3.6B | CHF 422.1B | CHF 238.80 | 0.86% down | 25% up | ||
| 9 | Vertex PharmaceuticalsVRTX · Health Care | CHF 3.3B | CHF 111.2B | CHF 438.51 | 2.94% down | 27% up | ||
| 10 | ZoetisZTS · Health Care | CHF 2.3B | CHF 27.6B | CHF 68.04 | 5.59% down | 26% down | ||
| 11 | United TherapeuticsUTHR · Health Care | CHF 1.1B | CHF 20.1B | CHF 470.88 | 3.16% down | 22% up | ||
| 12 | Royalty PharmaRPRX · Health Care | CHF 649.3M | CHF 32.8B | CHF 57.03 | 1.38% down | 79% up | ||
| 13 | PTC TherapeuticsPTCT · Health Care | CHF 574.9M | CHF 4.1B | CHF 49.12 | 3.16% down | 21% down | ||
| 14 | TG TherapeuticsTGTX · Health Care | CHF 376.6M | CHF 8.3B | CHF 54.64 | 1.88% down | 117% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | CHF 293.8M | CHF 10B | CHF 51.73 | 0.02% down | 17% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | CHF 264.2M | CHF 16.7B | CHF 124.50 | 1.06% down | 66% down | ||
| 17 | Ligand PharmaceuticalsLGND · Health Care | CHF 104.8M | CHF 4.8B | CHF 241.66 | 3.94% down | 50% up | ||
| 18 | Corcept TherapeuticsCORT · Health Care | CHF 83.9M | CHF 6B | CHF 54.73 | 4.15% down | 10% down | ||
| 19 | Amneal PharmaceuticalsAMRX · Health Care | CHF 60.7M | CHF 6.3B | CHF 18.01 | 2.24% down | 90% up | ||
| 20 | Arrowhead PharmaceuticalsARWR · Health Care | -CHF 1.4M | CHF 5.2B | CHF 36.76 | 1.25% up | 13% up | ||
| 21 | Mirum PharmaceuticalsMIRM · Health Care | -CHF 19.7M | CHF 5.3B | CHF 80.44 | 3.27% up | 34% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | -CHF 21.5M | CHF 3.9B | CHF 40.68 | 3.86% down | 45% up | ||
| 23 | VeradermicsMANE · Health Care | -CHF 59M | CHF 4.4B | CHF 104.76 | 0.38% down | 231% up | ||
| 24 | Belite BioBLTE · Health Care | -CHF 65.4M | CHF 5.2B | CHF 127.19 | 3.33% down | 43% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -CHF 88.8M | CHF 5.6B | CHF 82.17 | 1.91% up | 255% up | ||
| 26 | ErascaERAS · Health Care | -CHF 104.9M | CHF 4.2B | CHF 11.98 | 3.34% up | 395% up | ||
| 27 | Protagonist TherapeuticsPTGX · Health Care | -CHF 109.6M | CHF 6.8B | CHF 104.45 | 2.47% down | 51% up | ||
| 28 | Spyre TherapeuticsSYRE · Health Care | -CHF 130.7M | CHF 7.8B | CHF 82.22 | 3.77% down | 332% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | -CHF 136.7M | CHF 4B | CHF 71.44 | 1.01% up | 108% up | ||
| 30 | Edgewise TherapeuticsEWTX · Health Care | -CHF 141.3M | CHF 3.8B | CHF 34.67 | 0.48% down | 86% up | ||
| 31 | Axsome TherapeuticsAXSM · Health Care | -CHF 154.3M | CHF 6B | CHF 114.27 | 1.25% up | 6% down | ||
| 32 | Definium TherapeuticsDFTX · Health Care | -CHF 154.8M | CHF 3.4B | CHF 24.83 | 1.24% up | 168% up | ||
| 33 | Rhythm PharmaceuticalsRYTM · Health Care | -CHF 165.5M | CHF 6.8B | CHF 98.37 | 1.88% down | 18% up | ||
| 34 | Elanco Animal HealthELAN · Health Care | -CHF 195.4M | CHF 11.1B | CHF 22.14 | 1.54% down | 26% up | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -CHF 242.8M | CHF 7.8B | CHF 334.14 | 0.34% down | 27% down | ||
| 36 | Legend BiotechLEGN · Health Care | -CHF 250M | CHF 2.6B | CHF 13.56 | 0.92% down | 41% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | -CHF 255.4M | CHF 7.3B | CHF 261.84 | 1.87% up | 86% up | ||
| 38 | Cogent BiosciencesCOGT · Health Care | -CHF 277M | CHF 4.1B | CHF 23.36 | 0.25% down | 20% down | ||
| 39 | Ionis PharmaceuticalsIONS · Health Care | -CHF 321.2M | CHF 3.8B | CHF 22.92 | 0.62% down | 63% down | ||
| 40 | BridgeBio PharmaBBIO · Health Care | -CHF 617.3M | CHF 12.8B | CHF 65.84 | 0.22% up | 21% up | ||
| 41 | CytokineticsCYTK · Health Care | -CHF 661.1M | CHF 6B | CHF 43.34 | 0.27% up | 19% down | ||
| 42 | Summit TherapeuticsSMMT · Health Care | -CHF 909.2M | CHF 7.1B | CHF 8.90 | 0.67% up | 36% down | ||
| 43 | InsmedINSM · Health Care | -CHF 1.1B | CHF 26.7B | CHF 121.67 | 20.58% up | 40% down | ||
| 44 | ViatrisVTRS · Health Care | -CHF 3B | CHF 19.2B | CHF 16.74 | 1.97% down | 99% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8422 CHF).
Questions and answers
Which pharmaceutical companies in the United States rank first by earnings?
Johnson & Johnson (CHF 22.6B), Eli Lilly (CHF 17.4B) and Merck & Co (CHF 15.4B) are the top three of the 44 pharmaceutical companies in the United States ranked by earnings as of 20 Nov 2026, 05:38 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by earnings.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by earnings have a combined market value of CHF 3.15T as of 20 Nov 2026, 05:38 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by earnings”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.